← Back to Clinical Trials
Recruiting NCT05315752

NCT05315752 Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05315752
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Saint Pierre
Condition Obesity
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2022-04-22
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type OBSERVATIONAL
Interventions
Bariatric surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2022-04-22 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Prospective study with inclusion of bariatric surgery candidates with diagnosed Obstructive Sleep Apnea and requiring treatment with Continuous Positive Air Pressure, aiming to evaluate at 2-6-12 months after bariatric surgery whether the relationship between biometric changes (reduction in neck circumference, height, waist/hip ratio, and fat and lean mass) and the resolution of OSA is better than the relationship between these biometric changes and BMI reduction.

Eligibility Criteria

Inclusion Criteria: Any informed person who is * eligible for bariatric surgery: with severe obesity (BMI≥35-40) or morbid obesity (BMI≥40), with co-morbidities, who have not lost enough weight with prior lifestyle adaptations (balanced diet, physical activity) AND * with diagnosed obstructive sleep apnoea (OSA) (AHI \> 15/hr on polysomnography) AND * requiring treatment with Continuous Positive Air Pressure (CPAP) Exclusion Criteria: * Cognitive impairment - language barrier

Contact & Investigator

Central Contact

Marie BRUYNEEL, Prof.

✉ marie.bruyneel@stpierre-bru.be

📞 +3225353686

Frequently Asked Questions

Who can join the NCT05315752 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05315752 currently recruiting?

Yes, NCT05315752 is actively recruiting participants. Contact the research team at marie.bruyneel@stpierre-bru.be for enrollment information.

Where is the NCT05315752 trial being conducted?

This trial is being conducted at Brussels, Belgium, Brussels, Belgium.

Who is sponsoring the NCT05315752 clinical trial?

NCT05315752 is sponsored by Centre Hospitalier Universitaire Saint Pierre. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology